BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25923552)

  • 1. Intensive diabetes therapy and ocular surgery in type 1 diabetes.
    ; Aiello LP; Sun W; Das A; Gangaputra S; Kiss S; Klein R; Cleary PA; Lachin JM; Nathan DM
    N Engl J Med; 2015 Apr; 372(18):1722-33. PubMed ID: 25923552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
    ; de Boer IH; Sun W; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Zinman B
    N Engl J Med; 2011 Dec; 365(25):2366-76. PubMed ID: 22077236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
    White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
    J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
    ; Orchard TJ; Nathan DM; Zinman B; Cleary P; Brillon D; Backlund JY; Lachin JM
    JAMA; 2015 Jan; 313(1):45-53. PubMed ID: 25562265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    ; Nathan DM; Bebu I; Hainsworth D; Klein R; Tamborlane W; Lorenzi G; Gubitosi-Klug R; Lachin JM
    N Engl J Med; 2017 Apr; 376(16):1507-1516. PubMed ID: 28423305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
    Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
    Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Cleary PA; Orchard TJ; Genuth S; Wong ND; Detrano R; Backlund JY; Zinman B; Jacobson A; Sun W; Lachin JM; Nathan DM;
    Diabetes; 2006 Dec; 55(12):3556-65. PubMed ID: 17130504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
    Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
    Nathan DM; Cleary PA; Backlund JY; Genuth SM; Lachin JM; Orchard TJ; Raskin P; Zinman B;
    N Engl J Med; 2005 Dec; 353(25):2643-53. PubMed ID: 16371630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
    Genuth S
    Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.
    Martin CL; Albers J; Herman WH; Cleary P; Waberski B; Greene DA; Stevens MJ; Feldman EL;
    Diabetes Care; 2006 Feb; 29(2):340-4. PubMed ID: 16443884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.